Stockscreener 앱 받기
4.89%
전일 마감가:
$1.33
열려 있는:
$1.32
하루 거래량:
1.41M
Relative Volume:
0.19
시가총액:
$893.70M
수익:
$29.48M
순이익/손실:
$-201.19M
주가수익비율:
-4.3438
EPS:
-0.32
순현금흐름:
$-216.50M
1주 성능:
-0.36%
1개월 성능:
+20.26%
6개월 성능:
-10.00%
1년 성능:
-58.23%
1일 변동 폭
$1.32
$1.40
1주일 범위
$1.30
$1.43
52주 변동 폭
$1.04
$3.68
제론 Stock (GERN) Company Profile
명칭
Geron Corp
전화
(650) 473-7700
주소
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
GERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.40 | 849.01M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.92 | 116.51B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
786.09 | 82.52B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.51 | 52.67B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
849.39 | 52.08B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
176.44 | 37.70B | 447.02M | -1.18B | -906.14M | -6.1812 |
제론 Stock (GERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Sell |
| 2025-05-08 | 다운그레이드 | Scotiabank | Sector Outperform → Sector Perform |
| 2025-02-27 | 다운그레이드 | B. Riley Securities | Buy → Neutral |
| 2025-02-26 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | 개시 | H.C. Wainwright | Buy |
| 2024-10-16 | 개시 | Scotiabank | Sector Outperform |
| 2024-09-09 | 개시 | Leerink Partners | Outperform |
| 2024-04-30 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-04-29 | 개시 | TD Cowen | Buy |
| 2024-03-15 | 재확인 | Needham | Buy |
| 2023-09-12 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-03-28 | 개시 | Goldman | Neutral |
| 2022-10-28 | 개시 | Wedbush | Outperform |
| 2022-07-28 | 재개 | B. Riley Securities | Buy |
| 2021-11-02 | 개시 | Robert W. Baird | Outperform |
| 2021-02-18 | 재개 | B. Riley Securities | Buy |
| 2020-08-03 | 개시 | Stifel | Buy |
| 2019-11-19 | 재개 | B. Riley FBR | Buy |
| 2019-09-03 | 개시 | H.C. Wainwright | Buy |
| 2019-08-15 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-04-09 | 업그레이드 | Needham | Hold → Buy |
| 2019-01-31 | 업그레이드 | B. Riley FBR | Neutral → Buy |
| 2018-10-02 | 다운그레이드 | B. Riley FBR | Buy → Neutral |
| 2018-07-05 | 개시 | B. Riley FBR, Inc. | Buy |
| 2016-09-13 | 재확인 | FBR & Co. | Outperform |
| 2016-09-13 | 재확인 | FBR Capital | Outperform |
| 2015-12-07 | 재확인 | Piper Jaffray | Overweight |
| 2015-04-21 | 개시 | Oppenheimer | Outperform |
| 2014-06-12 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-12 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2013-12-10 | 재확인 | MLV & Co | Buy |
| 2013-12-10 | 업그레이드 | Needham | Hold → Buy |
| 2013-11-08 | 재확인 | MLV & Co | Buy |
| 2013-10-16 | 개시 | MLV & Co | Buy |
| 2012-08-30 | 개시 | Stifel Nicolaus | Buy |
| 2012-06-28 | 개시 | Needham | Hold |
모두보기
제론 주식(GERN)의 최신 뉴스
How Geron Corporation stock compares to market leadersJuly 2025 Price Swings & Precise Buy Zone Identification - Улправда
Geron (NASDAQ:GERN) Shares Down 3.9%What's Next? - MarketBeat
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation (GERN) Restructuring to Lower Operating Expenses as it Eyes Profitability in 2026 - Yahoo Finance
Geron (NASDAQ:GERN) Stock Price Up 5.6%Here's What Happened - MarketBeat
14 Best Multibagger Penny Stocks to Buy Right Now - Insider Monkey
Geron Corporation (NASDAQ: GERN) plans workforce cuts, expects $18M charges - Stock Titan
Squarepoint Ops LLC Increases Stock Position in Geron Corporation $GERN - MarketBeat
Geron (NASDAQ:GERN) Trading Up 8.2%What's Next? - MarketBeat
Geron Stock (NASDAQ: GERN) News Today: Restructuring, Analyst Ratings, and 2026 Catalysts (Dec. 12, 2025) - ts2.tech
Geron stock falls as H.C. Wainwright reiterates Neutral rating amid restructuring - Investing.com
Praxis tees up another approval filing; Geron turns to layoffs - Yahoo Finance
Geron Corporation (NASDAQ:GERN) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Geron Corporation (GERN) Presents New Data at the 67th American Society of Hematology 2025 Annual Meeting - Finviz
Foster City drug maker Geron to lay off one-third of staff under new CEOSan Francisco Business Times - The Business Journals
Geron Corporation: Can Restructuring Bring The Stock Back To Life? I'm On Sidelines (GERN) - Seeking Alpha
Geron Corporation (GERN) Announces Significant Workforce Reducti - GuruFocus
Geron (GERN) Initiates Strategic Restructuring for Long-Term Gro - GuruFocus
Geron to cut workforce by one-third in strategic restructuring - Investing.com
Geron Corporation Announces Strategic Restructuring to Enhance RYTELO® U.S. Commercial Strategy and Reduce Operating Expenses - Quiver Quantitative
Geron (Nasdaq: GERN) plans one-third cut as 2026 operating expenses expected below 2025 - Stock Titan
Geron stock rating reiterated as Neutral by H.C. Wainwright - Investing.com
Geron (GERN) Highlights Promising ASH 2025 Data on RYTELO - GuruFocus
Geron reports early cytopenia may signal response in MDS patients - Investing.com
Geron Corporation Presents New Data on Imetelstat at ASH 2025, Highlighting Clinical Benefits in Lower-Risk Myelodysplastic Syndromes and Myelofibrosis - Quiver Quantitative
Geron (Nasdaq: GERN) presents ASH 2025 RYTELO data on LR-MDS cytopenias, survival trends - Stock Titan
How Geron Corporation (GON) stock correlates with oil marketsWeekly Gains Report & Daily Profit Focused Screening - Newser
Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points - Benzinga
What consensus target says about Geron Corporation (GON) stockJuly 2025 EndofMonth & High Conviction Buy Zone Picks - Newser
Will Geron Corporation (GON) stock keep raising dividends2025 Investor Takeaways & Reliable Volume Spike Alerts - Newser
Why Geron Corporation (GON) stock stays on buy listsStop Loss & Daily Stock Trend Reports - Newser
Geron Corporation $GERN Stake Increased by Geode Capital Management LLC - MarketBeat
Great week for Geron Corporation (NASDAQ:GERN) institutional investors after losing 71% over the previous year - simplywall.st
Geron Corporation (NASDAQ:GERN) is favoured by institutional owners who hold 64% of the company - Yahoo Finance
Geron Corporation $GERN Shares Sold by Segall Bryant & Hamill LLC - MarketBeat
Wall Street Turns Bullish on Geron Corporation (GERN) amid Rytelo Sales Push Plans - Insider Monkey
10 Fastest Growing Penny Stocks to Buy Now - Insider Monkey
Geron Corporation (GERN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Market reaction to Geron Corporation’s recent newsPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Will Geron Corporation stock gain from lower inflationWeekly Trend Recap & Weekly High Potential Alerts - newser.com
Will Geron Corporation (GON) stock extend growth storyWeekly Risk Report & Free AI Powered Buy and Sell Recommendations - newser.com
Why analysts maintain buy rating on Geron Corporation (GON) stockJuly 2025 Earnings & Reliable Entry Point Alerts - newser.com
Geron’s Survival Strategy Faces Critical Test - AD HOC NEWS
Will Geron Corporation stock rally after Fed decisions2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Why Geron Corporation (GON) stock is trending on social mediaWeekly Stock Summary & Weekly Market Pulse Alerts - newser.com
Published on: 2025-11-19 19:45:31 - newser.com
Can Geron Corporation (GON) stock resist broad market declinesIPO Watch & Advanced Swing Trade Entry Plans - newser.com
Is Geron Corporation stock cheap at current valuationMarket Weekly Review & Target Return Focused Picks - newser.com
Published on: 2025-11-19 14:50:12 - newser.com
Published on: 2025-11-19 10:47:42 - newser.com
Why Geron Corporation (GON) stock remains stable2025 Risk Factors & Expert Approved Trade Ideas - newser.com
제론 (GERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
제론 주식 (GERN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| LAWLIS V BRYAN | Director |
May 09 '25 |
Buy |
1.18 |
13,300 |
15,667 |
13,300 |
| Samuels Scott Alan | EVP, Chief Legal Officer |
Feb 27 '25 |
Buy |
1.61 |
15,000 |
24,150 |
26,682 |
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
0.31%
1.24%
자본화:
|
볼륨(24시간):